Meningococcal disease in New York City, 1973 to 1978. Recognition of groups y and W-135 as frequent pathogens
- PMID: 6775103
Meningococcal disease in New York City, 1973 to 1978. Recognition of groups y and W-135 as frequent pathogens
Abstract
In the period 1973 through 1978, the New York City Department of Health serogrouped 648 isolates of Neisseria meningitidis and investigated 259 cases if meningococcal meningitis and meningococcemia. Although meningitis and septicemia were mainly due to groups B and C, groups Y and W-135 caused nearly one third of the cases. There was no difference in mortalities when disease caused by the classic groups A, B, and C was compared with disease caused by the new serogroups X, Y, Z, W-135, and Z'. Most isolates from the respiratory tract were from the new serogroups, especially Z and Z' (some from patients with pneumonia), as were most of those from the genitourinary tract, anal canal, and miscellaneous sites. Group X was infrequently seen. Although most of the isolations of these groups of N meningitidis are apparently from asymptomatic carriers, Y and W-135 do cause a substantial number of acute symptomatic infections, in particular, septicemia.
Similar articles
-
'The wheel within a wheel': meningococcal trends.JAMA. 1980 Nov 14;244(19):2200-1. JAMA. 1980. PMID: 6775106 No abstract available.
-
Molecular characterization of Neisseria meningitidis B:NT:P1.14/162 clonal complex responsible of invasive meningococcal disease in the north of Italy.Diagn Microbiol Infect Dis. 2012 Apr;72(4):370-2. doi: 10.1016/j.diagmicrobio.2012.01.003. Epub 2012 Feb 6. Diagn Microbiol Infect Dis. 2012. PMID: 22313628
-
Association of meningococcal serogroups with the course of disease in the Netherlands, 1959-83.Bull World Health Organ. 1987;65(6):861-8. Bull World Health Organ. 1987. PMID: 3124970 Free PMC article.
-
Meningococcal disease: the advances and challenges of meningococcal disease prevention.Hum Vaccin. 2011 Aug;7(8):828-37. doi: 10.4161/hv.7.8.16270. Epub 2011 Aug 1. Hum Vaccin. 2011. PMID: 21832882 Review.
-
Considerations for controlling invasive meningococcal disease in high income countries.Vaccine. 2012 May 30;30 Suppl 2:B57-62. doi: 10.1016/j.vaccine.2011.12.093. Vaccine. 2012. PMID: 22607900 Review.
Cited by
-
Meningococcal infections in Scotland 1972-82.J Hyg (Lond). 1984 Oct;93(2):167-80. doi: 10.1017/s0022172400064688. J Hyg (Lond). 1984. PMID: 6438229 Free PMC article.
-
Decreased susceptibility to penicillin G and Tet M plasmids in genital and anorectal isolates of Neisseria meningitidis.Antimicrob Agents Chemother. 1994 Jul;38(7):1661-3. doi: 10.1128/AAC.38.7.1661. Antimicrob Agents Chemother. 1994. PMID: 7979304 Free PMC article.
-
A complicated simple fall--an atypical case of serogroup Y meningococcal pneumonia with secondary septicaemia and literature review.BMJ Case Rep. 2012 Apr 4;2012:bcr1120115095. doi: 10.1136/bcr.11.2011.5095. BMJ Case Rep. 2012. PMID: 22604203 Free PMC article. Review.
-
Epidemiological profile of meningococcal disease in the United States.Clin Infect Dis. 2010 Mar 1;50 Suppl 2(S2):S37-44. doi: 10.1086/648963. Clin Infect Dis. 2010. PMID: 20144015 Free PMC article. Review.
-
Prospects for vaccine prevention of meningococcal infection.Clin Microbiol Rev. 2006 Jan;19(1):142-64. doi: 10.1128/CMR.19.1.142-164.2006. Clin Microbiol Rev. 2006. PMID: 16418528 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical